Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 457.47 million. The enterprise value is 537.92 million.

Market Cap	457.47M
Enterprise Value	537.92M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 17.66 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	17.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.25%
Owned by Institutions (%)	54.14%
Float	12.09M

Valuation Ratios

The trailing PE ratio is 23.32 and the forward PE ratio is 17.25.

PE Ratio	23.32
Forward PE	17.25
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	46.16
P/FCF Ratio	64.66
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.33, with an EV/FCF ratio of 76.03.

EV / Earnings	27.42
EV / Sales	1.02
EV / EBITDA	9.33
EV / EBIT	12.78
EV / FCF	76.03

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.48.

Current Ratio	1.64
Quick Ratio	0.73
Debt / Equity	0.48
Debt / EBITDA	2.20
Debt / FCF	17.94
Interest Coverage	5.72

Financial Efficiency

Return on equity (ROE) is 8.13% and return on invested capital (ROIC) is 7.12%.

Return on Equity (ROE)	8.13%
Return on Assets (ROA)	5.20%
Return on Capital (ROIC)	7.12%
Revenue Per Employee	11.68M
Profits Per Employee	436,022
Employee Count	45
Asset Turnover	1.04
Inventory Turnover	3.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.62% in the last 52 weeks. The beta is 0.38, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-29.62%
50-Day Moving Average	26.33
200-Day Moving Average	31.03
Relative Strength Index (RSI)	50.79
Average Volume (20 Days)	11,925

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 525.55 million and earned 19.62 million in profits.

Revenue	525.55M
Gross Profit	210.31M
Operating Income	42.10M
Pretax Income	27.15M
Net Income	19.62M
EBITDA	55.26M
EBIT	42.10M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 46.47 million in cash and 126.92 million in debt, giving a net cash position of -80.46 million or -4.56 per share.

Cash & Cash Equivalents	46.47M
Total Debt	126.92M
Net Cash	-80.46M
Net Cash Per Share	-4.56
Equity (Book Value)	264.13M
Book Value Per Share	n/a
Working Capital	102.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.27 million and capital expenditures -2.20 million, giving a free cash flow of 7.08 million.

Operating Cash Flow	9.27M
Capital Expenditures	-2.20M
Free Cash Flow	7.08M
FCF Per Share	0.40

Full Cash Flow Statement

Margins

Gross margin is 40.02%, with operating and profit margins of 8.01% and 3.73%.

Gross Margin	40.02%
Operating Margin	8.01%
Pretax Margin	5.17%
Profit Margin	3.73%
EBITDA Margin	10.51%
EBIT Margin	8.01%
FCF Margin	1.35%

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	1.55%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a